Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism-Reference-Cited by-同舟云学术

Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism

Published:2017-02-13 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Bettiga Arianna,Aureli Massimo,Colciago Giorgia,Murdica Valentina,Moschini Marco,Lucianò Roberta,Canals Daniel,Hannun Yusuf,Hedlund Petter,Lavorgna Giovanni,Colombo Renzo,Bassi Rosaria,Samarani Maura,Montorsi Francesco,Salonia Andrea,Benigni Fabio

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep42157.pdf

Reference51 articles.

1. Richter, S. & Sridhar, S. S. New Directions for Biologic Targets in Urothelial Carcinoma. Molecular Cancer Therapeutics 11, 1226–1235, doi: 10.1158/1535-7163.Mct-11-0756 (2012).

2. Strittmatter, F. et al. Expression of Fatty Acid Amide Hydrolase (FAAH) in Human, Mouse, and Rat Urinary Bladder and Effects of FAAH Inhibition on Bladder Function in Awake Rats. Eur Urol, doi: 10.1016/j.eururo.2011.09.002 (2011).

3. Bifulco, M., Laezza, C., Pisanti, S. & Gazzerro, P. Cannabinoids and cancer: pros and cons of an antitumour strategy. Br J Pharmacol 148, 123–135, doi: 10.1038/sj.bjp.0706632 (2006).

4. Alexander, A., Smith, P. F. & Rosengren, R. J. Cannabinoids in the treatment of cancer. Cancer Lett 285, 6–12, doi: 10.1016/j.canlet.2009.04.005 (2009).

5. Hermanson, D. J. & Marnett, L. J. Cannabinoids, endocannabinoids, and cancer. Cancer and Metastasis Reviews 30, 599–612, doi: 10.1007/s10555-011-9318-8 (2011).

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the 1,3-benzoxazine chemotype for cannabinoid receptor 2 as a promising anti-cancer therapeutic;European Journal of Medicinal Chemistry;2023-11

2. Targeted and untargeted urinary metabolic profiling of bladder cancer;Journal of Pharmaceutical and Biomedical Analysis;2023-09

3. Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and their Therapeutic Potential;Current Medicinal Chemistry;2023-04

4. Cannabidiol as a Promising Therapeutic Option in IC/BPS: In Vitro Evaluation of Its Protective Effects against Inflammation and Oxidative Stress;International Journal of Molecular Sciences;2023-03-06

5. Metabolomic and elemental profiling of blood serum in bladder cancer;Journal of Pharmaceutical Analysis;2022-12